New Cervical Cancer Regime Cuts Death Rate by 40 Percent, Study Shows

A large-scale study has shown that a new treatment protocol cuts the risk of death from cervical cancer by 40 percent. Researchers at University College London (UCL) and University College London Hospital (UCLH) have completed a long-term follow-up of patients given a short course of chemotherapy before chemoradiation (a combination of chemotherapy and radiotherapy). The trial began in November 2012 and ended in November 2022. The findings, which follow on from those first presented in October 2023, show a 40 percent reduction in the risk of death and a 35 percent reduction in the risk of cancer returning within at least five years. At the time of the initial results, Cancer Research UK hailed the shift as the biggest improvement in cervical cancer treatment in more than 20 years....